217 related articles for article (PubMed ID: 19490140)
21. Successful suppression using Rituximab of a factor VIII inhibitor in a boy with severe congenital haemophilia: an example of a significant decrease of treatment costs.
Mateo J; Badell I; Forner R; Borrell M; Tizzano E; Fontcuberta J
Thromb Haemost; 2006 Feb; 95(2):386-7. PubMed ID: 16493502
[No Abstract] [Full Text] [Related]
22. Rituximab as an adjuvant therapy to immune tolerance in a haemophilia A boy with high inhibitor titre.
Chuansumrit A; Husapadol S; Wongwerawattanakoon P; Hongeng S; Sirachainan N; Pakakasama S
Haemophilia; 2007 Jan; 13(1):108-10. PubMed ID: 17212736
[TBL] [Abstract][Full Text] [Related]
23. [Bullous pemphigoid and acquired haemophilia].
Kluger N; Navarro R; Pallure V; Guillot B
Ann Dermatol Venereol; 2011 May; 138(5):422-3. PubMed ID: 21570569
[No Abstract] [Full Text] [Related]
24. Acquired hemophilia: a case report of 2 patients with acquired factor VIII inhibitor treated with rituximab plus a short course of steroid and review of the literature.
Alvarado Y; Yao X; Jumper C; Hardwicke F; D'Cunha N; Cobos E
Clin Appl Thromb Hemost; 2007 Oct; 13(4):443-8. PubMed ID: 17911199
[TBL] [Abstract][Full Text] [Related]
25. Rituximab as a single agent in the management of adult patients with haemophilia A and inhibitors: marked reduction in inhibitor level and clinical improvement in bleeding but failure to eradicate the inhibitor.
Aleem A; Saidu A; Abdulkarim H; Al-Diab AR; Al-Sagheer A; Qayum A; Al-Momen AK
Haemophilia; 2009 Jan; 15(1):210-6. PubMed ID: 19149851
[TBL] [Abstract][Full Text] [Related]
26. [Long-term response to rituximab in a patient with acquired hemophilia].
García-Chávez J; Vela-Ojeda J; García-Manzano A; Majluf-Cruz A
Rev Invest Clin; 2011; 63(2):210-2. PubMed ID: 21717725
[TBL] [Abstract][Full Text] [Related]
27. The literature on inhibitors: articles that influence my management of patients with hemophilia A and high-titer inhibitors.
Leissinger CA
Am J Hematol; 2012 May; 87 Suppl 1():S23-6. PubMed ID: 22473571
[TBL] [Abstract][Full Text] [Related]
28. Exposure to factor VIII and prediction of inhibitor development: exposure days vs. danger days, or both?
Hermans C; Astermark J; De Moerloose P
J Thromb Haemost; 2012 Oct; 10(10):2194-6. PubMed ID: 22846047
[No Abstract] [Full Text] [Related]
29. Current management of acquired factor VIII inhibitors.
Barnett B; Kruse-Jarres R; Leissinger CA
Curr Opin Hematol; 2008 Sep; 15(5):451-5. PubMed ID: 18695367
[TBL] [Abstract][Full Text] [Related]
30. The use of rituximab in two children with allo-antibodies towards factor VIII.
Curry N; Stanworth S; Keeling D
Br J Haematol; 2006 Apr; 133(2):214-6. PubMed ID: 16611318
[No Abstract] [Full Text] [Related]
31. Rituximab for adolescents with haemophilia and high titre inhibitors.
Fox RA; Neufeld EJ; Bennett CM
Haemophilia; 2006 May; 12(3):218-22. PubMed ID: 16643204
[TBL] [Abstract][Full Text] [Related]
32. Successful response to rituximab in two cases of acquired haemophilia refractory to standard-therapy.
Machado P; Raya JM; Martín T; Morabito L; Brito ML; Rodríguez-Martín JM
Int J Hematol; 2008 Jun; 87(5):545-549. PubMed ID: 18414981
[TBL] [Abstract][Full Text] [Related]
33. How I treat inhibitors in haemophilia.
Makris M; Hay CR; Gringeri A; D'Oiron R
Haemophilia; 2012 Jul; 18 Suppl 4():48-53. PubMed ID: 22726083
[TBL] [Abstract][Full Text] [Related]
34. [Treatment of hemophilia with immunologic inhibitor of factor VIII by using "activated" coagulant fractions].
Sultan Y; Brouet JC
Nouv Presse Med; 1975 Oct; 4(36):2571-4. PubMed ID: 1081682
[TBL] [Abstract][Full Text] [Related]
35. Low-dose rituximab in the treatment of acquired haemophilia.
Yao Q; Zhu X; Liu Y; Zhang F; Yuan T; Xu J; Wang X
Hematology; 2014 Dec; 19(8):483-6. PubMed ID: 24611711
[TBL] [Abstract][Full Text] [Related]
36. Acquired hemophilia A with sigmoid colon cancer: successful treatment with rituximab followed by sigmoidectomy.
Ichikawa S; Kohata K; Okitsu Y; Suzuki M; Nakajima S; Yamada MF; Onishi Y; Yamamoto J; Suzuki S; Ishizawa K; Kameoka J; Harigae H
Int J Hematol; 2009 Jul; 90(1):33-36. PubMed ID: 19484333
[TBL] [Abstract][Full Text] [Related]
37. Rituximab for autoimmune haemophilia: a proposed treatment algorithm.
Aggarwal A; Grewal R; Green RJ; Boggio L; Green D; Weksler BB; Wiestner A; Schechter GP
Haemophilia; 2005 Jan; 11(1):13-9. PubMed ID: 15660983
[TBL] [Abstract][Full Text] [Related]
38. Acquired hemophilia: a clinical experience.
Mirza MA; Khimani F; Rogers J
W V Med J; 2010; 106(7):32-5. PubMed ID: 21932489
[No Abstract] [Full Text] [Related]
39. Rituximab alone or in association with corticosteroids in the treatment of acquired factor VIII inhibitors: report of two cases.
Berezné A; Stieltjes N; Le-Guern V; Teixeira L; Billy C; Roussel-Robert V; Flaujac C; Horellou MH; Guillevin L; Mouthon L
Transfus Med; 2006 Jun; 16(3):209-12. PubMed ID: 16764602
[TBL] [Abstract][Full Text] [Related]
40. [Acquired factor VIII deficiency treated with cyclosporine].
Leinøe EB; Jørgensen M; Nielsen JD
Ugeskr Laeger; 1999 Aug; 161(34):4762-3. PubMed ID: 10500467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
